每年研究成果
每年研究成果
- 3結果
搜尋結果
-
2023
Correction to: Hydroxychloroquine (HCQ) Modulates Autophagy and Oxidative DNA Damage Stress in Hepatocellular Carcinoma to Overcome Sorafenib Resistance via TLR9/SOD1/hsa-miR-30a-5p/Beclin-1 Axis (Cancers, (2021), 13, 13, (3227), 10.3390/cancers13133227)
Chen, M. Y., Yadav, V. K., Chu, Y. C., Ong, J. R., Huang, T. Y., Lee, K. F., Lee, K. H., Yeh, C. T. & Lee, W. H., 2月 2023, 於: Cancers. 15, 4, 1028.研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
開啟存取 -
2019
Correction to: The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity (Clinical & Experimental Metastasis, (2018), 35, 7, (663-677), 10.1007/s10585-018-9919-5)
Lai, S. W., Bamodu, O. A., Tsai, W. C., Chang, Y. M., Lee, W. H., Yeh, C. T. & Chao, T. Y., 2月 15 2019, 於: Clinical and Experimental Metastasis. 36, 1, p. 67 1 p.研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
2 引文 斯高帕斯（Scopus） -
2018
Correction: S100A9+ MDSC and TAM-mediated EGFR-TKI resistance in lung adenocarcinoma: The role of RELB [Oncotarget., 9, (2018), (7631-7643)] DOI: 10.18632/oncotarget.24146
Feng, P. H., Yu, C. T., Chen, K. Y., Luo, C. S., Wu, S. M., Liu, C. Y., Kuo, L. W., Chan, Y. F., Chen, T. T., Chang, C. C., Lee, C. N., Chuang, H. C., Lin, C. F., Han, C. L., Lee, W. H. & Lee, K. Y., 7月 31 2018, 於: Oncotarget. 9, 59, p. 31559 1 p.研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審